Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 181-190 of 283 for Lung cancer

Edit search filters
  1. A Study Of Rovalpituzumab Tesirine As Maintenance Therapy Following First-Line Platinum-Based Chemotherapy In Participants With Extensive Stage Small Cell Lung Cancer (MERU)

    Rochester, MN

  2. Phase III Open Label First Line Therapy Study Of MEDI 4736 (Durvalumab) With Or Without Tremelimumab Versus SOC In Non Small-Cell Lung Cancer (NSCLC).

    Scottsdale/Phoenix, AZ

  3. Phase II Trial Of Standard Chemotherapy +Various Proton Beam Therapy (PBT) Doses For Unresectable Stage 2/3 Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. Specialized Radiation Therapy And Chemotherapy In Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. DAREON™-5: A Study To Test Whether Different Doses Of BI 764532 Help People With Small Cell Lung Cancer Or Other Neuroendocrine Cancers

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Testing The Addition Of High Dose, Targeted Radiation To The Usual Treatment For Locally-Advanced Inoperable Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Study Of Pembrolizumab (MK-3475) Compared To Platinum-Based Chemotherapies In Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)

    Rochester, MN

  8. A Study Of ASP8273 Versus Erlotinib Or Gefitinib As First-Line Treatment For Patients With Stage IIIB/IV Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. Adding The Immunotherapy Drug Cemiplimab To Usual Treatment For People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy And Immunotherapy (An Expanded Lung-MAP Treatment Trial)

    Rochester, MN

  10. Study Of Two Doses Of MK-3475 (Pembrolizumab) Versus Docetaxel In Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)

    Rochester, MN

.

Mayo Clinic Footer